ELOX Eloxx Pharmaceuticals, Inc.
$13.34▲ +0.76%
Healthcare
Other
After hours
$13.25▼ -0.67%
Oct 27, 4:02 PM ET
Volume 9.6K
Avg Volume (10D) 25.7K
Key Metrics & Fundamentals
Market Cap
$53.85M
P/E Ratio
3.8
Div Yield
0.00%
52W Range
8.20 - 23.40
% vs 50 MA
-14.68%
% vs 200 MA
70.08%
RSI-14
43.9
MACD Histogram
+0.0400
Beta (1Y vs SPY)
-908.55
Free Cash Flow
-$4.79M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.43M
COGS
–
Operating Exp
$4.45M
Operating Income
-$4.45M
EBIT
-$4.45M
Pretax Income
-$4.50M
Net Income
-$4.50M
EPS (Diluted)
-0.66
Price & Volume History
Loading chart…
Recent News
Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D., Chief Medical Officer
PR Newswire · Oct 20, 2026 9:31 AM ET
Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors
PR Newswire · Oct 19, 2026 4:05 PM ET
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
PR Newswire · Sep 11, 2026 7:30 AM ET
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
PR Newswire · Aug 12, 2026 6:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ELOX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.